Clear Search

Books+ Search Results

Format: Is
Is Is Not
Online
Subject (Genre): Is
Is Is Not
Legislative hearings
Subject with Hierarchy: Is
Is Is Not
Pharmaceutical industry

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Remove Online Limit
Viewing Online Items
1.
The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183063
Location
Yale Internet Resource >> None
Format
Books / Online
2.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo182511
Location
Yale Internet Resource >> None
Format
Books / Online
3.
No time to wait : proposals to lower prescription drug costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Phoenix, Arizona, April 12, 2022
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo182961
Location
Yale Internet Resource >> None
Format
Books / Online
4.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183702
Location
Yale Internet Resource >> None
Format
Books / Online
5.
Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo186472
Location
Yale Internet Resource >> None
Format
Books / Online
6.
Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo185727
Location
Yale Internet Resource >> None
Format
Books / Online
7.
Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo156915
Location
Yale Internet Resource >> None
Format
Books / Online
8.
Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : United States Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo187077
Location
Yale Internet Resource >> None
Format
Books / Online
9.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo153433
Location
Yale Internet Resource >> None
Format
Books / Online
10.
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo150498
Location
Yale Internet Resource >> None
Format
Books / Online
11.
The role of Purdue Pharma and the Sackler family in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
12.
The SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo171680
Location
Yale Internet Resource >> None
Format
Books / Online
13.
Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo130776
Location
Yale Internet Resource >> None
Format
Books / Online
14.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo146986
Location
Yale Internet Resource >> None
Format
Books / Online
15.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo152475
Location
Yale Internet Resource >> None
Format
Books / Online
16.
Unsustainable drug prices : testimony from the CEOs : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo149312
Location
Yale Internet Resource >> None
Format
Books / Online
17.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
https://purl.fdlp.gov/GPO/gpo116408
Location
Yale Internet Resource >> None
Format
Books / Online
18.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
19.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
20.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
21.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session, February 28, 2019
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
https://purl.fdlp.gov/GPO/gpo124181
Location
Yale Internet Resource >> None
Format
Books / Online
22.
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo113215
Location
Yale Internet Resource >> None
Format
Books / Online
23.
Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
Author
United States. Congress. House. Committee on Oversight and Government Reform, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo82526
Location
Yale Internet Resource >> None
Format
Books / Online
24.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo86757
Location
Yale Internet Resource >> None
Format
Books / Online
25.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo77020
Location
Yale Internet Resource >> None
Format
Books / Online